Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology. Its core strategy is to keep overhead and infrastructure costs low while accelerating the ability to trigger liquidity events. With this model, they are running multiple drug discovery and development programs in parallel.